Corcept Therapeutics | Należności Handlowe



Trade Debtors Zmiana Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
Alaunos Therapeutics USD 5K 5K 2024-12
ANI Pharmaceuticals USD 221.73M 19.26M 2024-12
Ardelyx USD 57.7M 4.51M 2024-12
Aurora Cannabis CAD 49.52M 9.36M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
J&J USD 14.84B 1.33B 2024-12
Knight Therapeutics CAD 103M 8.1M 2024-09
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pacira USD 113.3M 12.65M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
TG Therapeutics USD 129.18M 13.46M 2024-12



Corcept Therapeutics Należności Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Apr 2025.